Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy
Biotech
Beam’s sickle cell results signal Casgevy, Lyfgenia showdown
The base-edited cell therapy kept patients from experiencing the most severe effects of the disease and prevented hospitalization for a year.
Michael Gibney
Nov 10, 2026 3:19pm
Artiva lays off staff after deaths, durability sink cell therapy
Oct 27, 2026 8:40am
Capricor secures reprieve as FDA extends DMD cell therapy review
Aug 25, 2026 3:26am
Kyverna begins rolling FDA submission for autoimmune CAR-T in SPS
May 12, 2026 4:27pm
Oryon shines out of stealth with $21M to fight Parkinson's
Mar 23, 2026 5:00am
Sana shares 14-month data for ‘functional cure’ diabetes program
Mar 13, 2026 10:55am